Zalunardo M P, Zollinger A, Spahn D R, Seifert B, Radjaipour M, Gautschi K, Pasch T
Institute of Anesthesiology, University Hospital Zurich, Switzerland.
J Clin Anesth. 1997 Mar;9(2):143-7. doi: 10.1016/S0952-8180(97)00239-0.
To investigate the effects of intravenous (IV) versus oral clonidine on alterations of heart rate (HR), mean arterial pressure (MAP), cardiac output (CO), and plasma-catecholamines due to endotracheal intubation.
Randomized, double-blind, placebo-controlled study.
University hospital surgery operating room.
33 ASA physical status I patients were randomly assigned to either receive clonidine 3 micrograms/kg IV immediately prior to anesthesia induction, clonidine 4 micrograms/kg orally 90 minutes prior to anesthesia induction, or placebo.
Insertion of a 14 G cannula in a large cubital vein for the determination of plasma-catecholamines using local anesthesia. Insertion of a radial artery catheter for measuring blood pressure (BP) using local anesthesia. Transthoracic echocardiography determined CO.
Heart rate, MAP, CO, and plasma-catecholamine concentrations were measured. Measurements were performed prior to induction, during intubation, and 10 minutes after intubation. During endotracheal intubation, MAP was significantly lower in the IV clonidine group compared with the placebo and the oral clonidine groups. Cardiac output was significantly lower in the IV clonidine group only. In contrast to the placebo group, norepinephrine plasma concentrations did not increase in either clonidine group. Significant alterations of epinephrine plasma concentrations due to intubation were not observed in either group. Hemodynamics after intubation were not impaired by clonidine treatment.
In conclusion, IV clonidine reduced stress response to endotracheal intubation compared with placebo. Oral clonidine at the dose used was less effective in blunting hemodynamic stress response than IV clonidine.
探讨静脉注射与口服可乐定对气管插管引起的心率(HR)、平均动脉压(MAP)、心输出量(CO)及血浆儿茶酚胺变化的影响。
随机、双盲、安慰剂对照研究。
大学医院手术室。
33例美国麻醉医师协会(ASA)身体状况I级患者被随机分为三组,分别在麻醉诱导前即刻静脉注射3微克/千克可乐定、在麻醉诱导前90分钟口服4微克/千克可乐定或给予安慰剂。
采用局部麻醉在大肘静脉插入14G套管针用于测定血浆儿茶酚胺。采用局部麻醉插入桡动脉导管用于测量血压(BP)。经胸超声心动图测定心输出量。
测量心率、MAP、CO及血浆儿茶酚胺浓度。在诱导前、插管期间及插管后10分钟进行测量。在气管插管期间,静脉注射可乐定组的MAP显著低于安慰剂组和口服可乐定组。仅静脉注射可乐定组的心输出量显著降低。与安慰剂组不同,可乐定组的去甲肾上腺素血浆浓度均未升高。两组均未观察到插管引起的肾上腺素血浆浓度有显著变化。可乐定治疗未损害插管后的血流动力学。
总之,与安慰剂相比,静脉注射可乐定可降低气管插管的应激反应。所用剂量的口服可乐定在减轻血流动力学应激反应方面不如静脉注射可乐定有效。